Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.
about
Understanding mechanisms of autoimmunity through translational research in vitiligo.Understanding autoimmunity of vitiligo and alopecia areata.Vitiligo Pathogenesis and Emerging Treatments.Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.[Systemic treatment of vitiligo : Balance and current developments].
P2860
Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Interfering with the IFN-γ/CXC ...... geted treatments for vitiligo.
@en
Interfering with the IFN-γ/CXC ...... geted treatments for vitiligo.
@nl
type
label
Interfering with the IFN-γ/CXC ...... geted treatments for vitiligo.
@en
Interfering with the IFN-γ/CXC ...... geted treatments for vitiligo.
@nl
prefLabel
Interfering with the IFN-γ/CXC ...... geted treatments for vitiligo.
@en
Interfering with the IFN-γ/CXC ...... geted treatments for vitiligo.
@nl
P2860
P1476
Interfering with the IFN-γ/CXC ...... geted treatments for vitiligo.
@en
P2093
John E Harris
Mehdi Rashighi
P2860
P356
10.3978/J.ISSN.2305-5839.2015.11.36
P577
2015-12-01T00:00:00Z